| 1 |
34025681 | Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone. | 2021 |
2 |
| 2 |
30612232 | Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy. | 2019 Mar |
1 |
| 3 |
31068561 | [Treatment of POEMS syndrome with lenalidomide and dexamethasone]. | 2019 |
3 |
| 4 |
29693175 | Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro. | 2018 Jun |
1 |
| 5 |
28488026 | Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms. | 2017 Jul |
1 |
| 6 |
27342494 | [Clinical Curative Efficacy of Lenalidomide Combined with Chemotherapy for Acute Leukemia and Its Impact on VEGF]. | 2016 Jun |
4 |
| 7 |
27748917 | Lenalidomide induces apoptosis and inhibits angiogenesis via caspase‑3 and VEGF in hepatocellular carcinoma cells. | 2016 Nov |
4 |
| 8 |
26255966 | Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder. | 2015 Oct 2 |
1 |
| 9 |
24212063 | Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. | 2014 Feb |
1 |
| 10 |
22488443 | Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation. | 2012 Jun |
2 |
| 11 |
22826791 | Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib. | 2012 Apr 12 |
2 |
| 12 |
21307145 | Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma. | 2011 Apr 1 |
1 |
| 13 |
18805433 | The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions. | 2009 Mar |
1 |